Expert Opinion on Drug Safety

Title Publication Date Language Citations
Association of temozolomide with progressive multifocal leukoencephalopathy: a disproportionality analysis integrated with network pharmacology2023/11/09English
Risk of serious skin and subcutaneous tissue disorders for nimesulide among the pediatric population: a jeopardy identified through the analysis of global individual case safety reports2023/11/01English
Drug-induced hypoglycemia: a disproportionality analysis of the FAERS database2023/11/09English
Balancing the risk of stroke and bleeding in atrial fibrillation patients with a history of falls2023/10/24English
Nail lichen planus treatment safety2023/12/01English
The safety of phthalate-containing medications used during pregnancy2023/04/03English
TBC and COVID: an interplay between two infections2023/04/03English
A retrospective study to evaluate Hy’s Law, DrILTox ALF score, Robles-Diaz model, and a new logistic regression model for predicting acute liver failure in Chinese patients with drug-induced liver injury2023/03/28English
Safety of mirogabalin and pregabalin in Japanese patients with neuropathic pain: a retrospective cohort study2023/03/21English
Association between methotrexate-induced Stevens-Johnson syndrome/toxic epidermal necrolysis and furosemide: a real-world disproportionality analysis2023/04/17English
Pharmacovigilance analysis of cardiac risks associated with Bruton tyrosine kinase inhibitors2023/04/19English
Superior stroke prevention with angiotensin receptor blockers compared with other antihypertensive drugs2023/02/01English
Non-opioid antinociceptive drugs : risk of respiratory depression and death related to concomitant use of gabapentinoids in addition to opioids2023/03/04English
Safety implications of concomitant administration of antidepressants and opioid analgesics in surgical patients2023/02/22English
Possible genetical predictors of efficacy and safety of budesonide-MMX in patients with mild-to-moderate ulcerative colitis, and safety comparison with methylprednisolone2023/02/23English
Risks of cardiovascular toxicities associated with ALK tyrosine kinase inhibitors in patients with non-small-cell lung cancer: a meta-analysis of randomized control trials2023/02/26English
Why are outcome-based drug safety research studies scarce? Insights into operational challenges and potential solutions2024/01/17English
Generic pharmaceuticals, regulatory aspects, bioequivalence investigation, and perception2024/01/17English
Reporting of tumor lysis syndrome with targeted therapy for hepatic cancer in the FDA adverse events reporting system2024/02/02English
Safety and effectiveness of rasagiline in patients with Parkinson’s disease in Japan: a post-marketing surveillance study2023/12/20English
A safety evaluation of ruxolitinib for the treatment of polycythemia vera2023/12/29English
Effects of adding adjuvants to propofol on the post-anesthesia cognitive function in patients undergoing gastroscopy/colonoscopy: a systematic review and meta-analysis2024/01/22English
Medications in dermatology are safer and more efficient than they used to be2020/02/21English
Advanced analytics – translating registry science into regulatory actions2020/03/11English
A comprehensive overview and safety evaluation of fremanezumab as a preventive therapy for migraine2020/03/09English
Somatostatin analog-induced pancreatic exocrine insufficiency: exploring our diagnostic strategy2021/04/19English
Is there any clinical or laboratory predictive factor for cetuximab-induced skin toxicity?2021/03/05English
Reply to Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis2018/11/18English
Addendum2018/03/08English
18th world congress of basic and clinical pharmacology: thought-provoking lectures on drug safety issues2019/10/01English